Tumor Atelectasis Gives Rise to a Solid Appearance in Pulmonary Adenocarcinomas on High-Resolution Computed Tomography

by Francesca Ambrosi, MD, Birgit Lissenberg-Witte, PhD, Emile Comans, MD, PhD, Ralf Sprengers, MD, PhD, Chris Dickhoff, MD, PhD, Idris Bahce, MD, PhD, Teodora Radonic, MD, PhD, Erik Thunnissen, MD, PhD
Published 2020-06-01

Salvage Surgery for Patients With Local Recurrence or Persistent Disease After Treatment With Chemoradiotherapy for SCLC

by Pieter J.M. Joosten, MD, Toon A. Winkelman, MD, David J. Heineman, MD, PhD, Sayed M.S. Hashemi, MD, Idris Bahce, MD, PhD, Suresh Senan, MD, PhD, Marinus A. Paul, MD, PhD, Koen J. Hartemink, MD, PhD, Max Dahele, MbChB., PhD, Chris Dickhoff, MD, PhD
Published 2021-05-01

The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter Analysis

by Merle I. Ronden, MD, Idris Bahce, MD, PhD, Niels J.M. Claessens, MD, Nicole Barlo, MD, Max R. Dahele, MD, PhD, Johannes M.A. Daniels, MD, PhD, Caroline Tissing-Tan, MD, Edo Hekma, MD, Sayed M.S. Hashemi, MD, Antoinet van der Wel, MD, Femke O.B. Spoelstra, MD, PhD, Wilko F.A. R. Verbakel, MD, PhD, Marian A. Tiemessen, MD, Marjolein van Laren, MD, Annemarie Becker, MD, PhD, Svitlana Tarasevych, MD, Cornelis J.A. Haasbeek, MD, PhD, Karen Maassen van den Brink, MD, Chris Dickhoff, MD, PhD, Suresh Senan, MRCP, FRCR, PhD
Published 2021-07-01